Line 45: | Line 45: | ||
<font size=3 color=#444444> | <font size=3 color=#444444> | ||
Conceived as a distributable platform for rapid point-of-care diagnostics, CascAID can be used to distinguish between bacterial and viral infections, thus minimizing the widespread use of antibiotics. | Conceived as a distributable platform for rapid point-of-care diagnostics, CascAID can be used to distinguish between bacterial and viral infections, thus minimizing the widespread use of antibiotics. | ||
− | |||
− | |||
− | |||
− | |||
Furthermore, Cas13a allows the fast design of target sequences, making our system adaptive to the emergence of new viral outbreaks or fast mutating pathogens. | Furthermore, Cas13a allows the fast design of target sequences, making our system adaptive to the emergence of new viral outbreaks or fast mutating pathogens. | ||
</font> | </font> | ||
</p> | </p> | ||
− | |||
</td></tr> | </td></tr> | ||
<tr><td class="no-padding" colspan=2 align=right valign=center height=10> | <tr><td class="no-padding" colspan=2 align=right valign=center height=10> |
Revision as of 21:11, 29 October 2017